Disc Medicine, Inc.
Disc Medicine, Inc. (IRON) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
iron · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Disc Medicine, Inc. (IRON) measures how much investors pay for each dollar of the company's trailing earnings. IRON's current PE ratio of N/A is calculated by dividing its stock price of $67.35 by its TTM earnings per share of -$6.28.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Disc Medicine, Inc.You IRON | $2.6B | N/A | — | -$6.28 |
 Ascentage Pharma Group International AAPG | $1.6B | N/A | — | -$13.58 |
 Adaptive Biotechnologies Corporation ADPT | $2.8B | N/A | — | -$0.39 |
 Apogee Therapeutics, Inc. APGE | $5.2B | N/A | — | -$4.22 |
 Celcuity Inc. CELC | $4.3B | N/A | — | -$3.37 |
 CG Oncology, Inc. Common stock CGON | $4.8B | N/A | — | -$2.08 |
 Legend Biotech Corporation LEGN | $5.6B | N/A | — | -$1.61 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-6.01 | — | |
2024-12-31 FY2024 | — | $-3.96 | — | |
2023-12-31 FY2023 | — | $-3.42 | — | |
2022-12-31 FY2022 | — | $-45.05 | — | |
2021-12-31 FY2021 | — | $-44.88 | — | |
2020-12-31 FY2020 | — | $-27.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Disc Medicine, Inc. (IRON) measures how much investors pay for each dollar of the company's trailing earnings. IRON's current PE ratio of N/A is calculated by dividing its stock price of $67.35 by its TTM earnings per share of -$6.28.
Frequently asked questions
IRON pe ratio · 6 questionsIRON's current PE ratio is N/A as of 2026-06-08, based on a stock price of $67.35 and TTM EPS of -$6.28. Data sourced from Financial Modeling Prep via IRON's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Disc Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08